Trial
NCT03595683
Pembrolizumab and EDP1503 in Advanced Melanoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
Merck Sharp & Dohme LLC; Evelo Biosciences, Inc.
Condition
Melanoma (Skin)
Intervention
Pembrolizumab
Why stopped
Drug supply no longer available.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-08